Finally, we confirmed the expression level of MYLK2 in PRAD and verified its regulatory effect on the invasion and metastatic ability of PRAD cells using in vitro experiments, thus revealing the relationship between ITH and PRAD. Here, MYLK2 is linked to prostate adenocarcinoma.